These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1943943)
1. Management of non-nephrotic hyperlipidaemia of chronic renal failure with simvastatin. Harris DC; Simons LA; Mitchell P; Stewart JH Med J Aust; 1991 Oct; 155(8):573. PubMed ID: 1943943 [No Abstract] [Full Text] [Related]
2. [Dyslipidemia in the uremic patient: the therapeutic role played by simvastatin]. Bellinghieri G; Angelé B; Savica V Clin Ter; 1992 Jan; 140(1 Pt 2):11-6. PubMed ID: 1559316 [TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome. Rabelink AJ; Hené RJ; Erkelens DW; Joles JA; Koomans HA Lancet; 1988 Dec; 2(8624):1335-8. PubMed ID: 2904053 [TBL] [Abstract][Full Text] [Related]
5. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients. Fiorini F; Patrone E; Castelluccio A Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167 [TBL] [Abstract][Full Text] [Related]
6. Cholesterol synthesis inhibitors in hyperlipidaemia. Mol MJ; Stuyt PM; Stalenhoef AF; van 't Laar A Lancet; 1988 Mar; 1(8585):597. PubMed ID: 2894538 [No Abstract] [Full Text] [Related]
7. Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety. Shepherd J Eur Heart J; 1995 Jan; 16(1):5-13. PubMed ID: 7737222 [No Abstract] [Full Text] [Related]
8. Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia. Hutchesson AC; Moran A; Jones AF J Clin Pharm Ther; 1994 Dec; 19(6):387-9. PubMed ID: 7876371 [TBL] [Abstract][Full Text] [Related]
9. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia]. Martínez-Castelao A Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262 [No Abstract] [Full Text] [Related]
17. The effect of simvastatin on dyslipemia in continuous ambulatory peritoneal dialysis patients. Dimitriadis A; Antoniou S; Hatzisavvas N; Pastore F; Kaldi I; Stangou M Perit Dial Int; 1993; 13 Suppl 2():S434-6. PubMed ID: 8399633 [TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome. Wanner C; Böhler J; Eckardt HG; Wieland H; Schollmeyer P Clin Nephrol; 1994 Mar; 41(3):138-43. PubMed ID: 8187355 [TBL] [Abstract][Full Text] [Related]
19. Management of patients with dyslipidaemia. Mann J; Chisholm A; Crooke M; Jackson R; Neutze J; North D; Swinburn B; White H; Wilcox J N Z Med J; 1995 Oct; 108(1010):444. PubMed ID: 7478355 [No Abstract] [Full Text] [Related]
20. Treatment of nephrotic hyperlipidemia with lovastatin. Elisaf M; Dardamanis M; Pappas M; Sferopoulos G; Siamopoulos KC Clin Nephrol; 1991 Jul; 36(1):50-2. PubMed ID: 1889153 [No Abstract] [Full Text] [Related] [Next] [New Search]